Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

NCT06593600 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Postural Orthostatic Tachycardia Syndrome (POTS)

Interventions

DRUG: REGN7544
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals